Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IBSS BIOMED is a Polish biotechnology company specializing in the development and production of immunobiological preparations, including vaccines, probiotics, and diagnostic kits. The company is widely recognized for its 'prOVag' brand, which offers oral and topical probiotics specifically designed to support women's urogenital health by restoring natural bacterial flora. In addition to women's health, IBSS BIOMED manufactures well-known probiotic brands such as Lakcid and Latopic, as well as bacterial lysates and vaccines for tuberculosis and diphtheria. Operating from its headquarters in Krakow, the company maintains GMP-certified manufacturing facilities and conducts research into live biotherapeutic products for various therapeutic areas. The company serves both domestic and international markets, leveraging decades of experience in microbiology and immunology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on prOVag.